Wuhan, China

Xiaoming Wu

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Xwpharma Ltd.. Active years: 2022-2026.

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Xiaoming Wu: Innovator in Synthetic Methods

Introduction

Xiaoming Wu is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of synthetic chemistry, particularly in the development of methods for synthesizing complex compounds. With a total of 4 patents to his name, Wu continues to push the boundaries of innovation in his area of expertise.

Latest Patents

One of Wu's latest patents focuses on the "Methods of synthesizing 4-valyloxybutyric acid." This patent outlines synthetic methods for the preparation of this compound, employing a diverse array of protecting group strategies and reaction conditions. Additionally, the patent discusses compounds that are useful as synthetic intermediates in the preparation of 4-valyloxybutyric acid.

Career Highlights

Xiaoming Wu is currently associated with Xwpharma Ltd., where he applies his expertise in synthetic methods to advance pharmaceutical research and development. His work has been instrumental in creating innovative solutions that enhance the efficiency of chemical synthesis.

Collaborations

Wu collaborates with talented individuals in his field, including Hao-Wei Shih and Xuan Zhang. These partnerships foster a dynamic environment for innovation and contribute to the success of their projects.

Conclusion

Xiaoming Wu is a dedicated inventor whose work in synthetic methods has made a significant impact in the field of chemistry. His innovative approaches and collaborations continue to drive advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…